Despite a challenging health care landscape, Vanderbilt University Medical Center continues to advance the highest-quality patient care, train the next generation of physician leaders and push forward the frontiers of biomedical science.

The role of inflammation in gastrointestinal cancer development was a prominent theme among guest speakers during the Vanderbilt-Ingram Cancer Center annual retreat held at the Vanderbilt Student Life Center.

Several Vanderbilt researchers have collaborated with this year's Nobel Chemistry winners.

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.